Literature DB >> 9210413

Expression of a variant surface glycoprotein of Trypanosoma gambiense in procyclic forms of Trypanosoma brucei shows that the cell type dictates the nature of the glycosylphosphatidylinositol membrane anchor attached to the glycoprotein.

F Paturiaux-Hanocq1, N Zitzmann, J Hanocq-Quertier, L Vanhamme, S Rolin, M Geuskens, M A Ferguson, E Pays.   

Abstract

Procyclic forms of Trypanosoma brucei have been genetically modified to express the major metacyclic variant surface glycoprotein (VSG variant AnTat 11.17) of Trypanosoma gambiense. The VSG is expressed in an intact membrane-bound form that can be detected over the entire plasma membrane, together with procyclin, and as a series of lower-molecular-mass fragments that are mostly soluble degradation products. The presence of degraded VSG in the cells and the culture medium suggests that VSG is not efficiently processed and/or efficiently folded when expressed in procyclic cells. The level of procyclin expressed on the surface of these cells is slightly reduced, although there is no difference in procyclin mRNA levels. The intact membrane-bound form of the VSG is N-glycosylated with oligomannose structures and contains a glycosylphosphatidylinositol (GPI) membrane anchor that can be biosynthetically labelled with [3H]ethanolamine. The anchor is sensitive to mammalian GPI-specific phospholipase D but, like the anchor of procyclin, it is resistant to the action of bacterial phosphatidylinositol-specific phospholipase C. This pattern of phospholipase sensitivity suggests that the GPI anchor acquired by VSG when expressed in procyclics is acylated on the inositol ring and therefore resembles a procyclic procyclin-type anchor rather than a trypomastigote VSG-type anchor with respect to the lipid structure. The VSG expressed in procyclics was sensitive to the action of a mixture of sialidase, beta-galactosidase and beta-hexosaminidase, suggesting that the VSG GPI anchor also contains a sialylated polylactosamine side-chain modification similar to that described for procyclin. These results indicate that the nature of the protein expressed has little influence on the post-translational modifications performed in the secretory pathway of procyclic trypanosomes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210413      PMCID: PMC1218505          DOI: 10.1042/bj3240885

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Homologous recombination and stable transfection in the parasitic protozoan Trypanosoma brucei.

Authors:  M G Lee; L H Van der Ploeg
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

2.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

3.  Glycolipid precursors for the membrane anchor of Trypanosoma brucei variant surface glycoproteins. I. Can structure of the phosphatidylinositol-specific phospholipase C sensitive and resistant glycolipids.

Authors:  S Mayor; A K Menon; G A Cross; M A Ferguson; R A Dwek; T W Rademacher
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

4.  Immunological purification and partial characterization of variant-specific surface antigen messenger RNA of Trypanosoma brucei brucei.

Authors:  M Lheureux; M Lheureux; T Vervoort; N Van Meirvenne; M Steinert
Journal:  Nucleic Acids Res       Date:  1979-10-10       Impact factor: 16.971

5.  Will the real Trypanosoma b. gambiense please stand up.

Authors:  W C Gibson
Journal:  Parasitol Today       Date:  1986-09

6.  Retention and degradation of proteins containing an uncleaved glycosylphosphatidylinositol signal.

Authors:  M C Field; P Moran; W Li; G A Keller; I W Caras
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

7.  Site of palmitoylation of a phospholipase C-resistant glycosylphosphatidylinositol membrane anchor.

Authors:  M A Ferguson
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

8.  The role of inositol acylation and inositol deacylation in GPI biosynthesis in Trypanosoma brucei.

Authors:  M L Güther; M A Ferguson
Journal:  EMBO J       Date:  1995-07-03       Impact factor: 11.598

9.  Requirements for glycosylphosphatidylinositol attachment are similar but not identical in mammalian cells and parasitic protozoa.

Authors:  P Moran; I W Caras
Journal:  J Cell Biol       Date:  1994-04       Impact factor: 10.539

10.  Procyclin gene expression and loss of the variant surface glycoprotein during differentiation of Trypanosoma brucei.

Authors:  I Roditi; H Schwarz; T W Pearson; R P Beecroft; M K Liu; J P Richardson; H J Bühring; J Pleiss; R Bülow; R O Williams
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  5 in total

1.  In vitro generation of human high-density-lipoprotein-resistant Trypanosoma brucei brucei.

Authors:  Sara D Faulkner; Monika W Oli; Rudo Kieft; Laura Cotlin; Justin Widener; April Shiflett; Michael J Cipriano; Sarah E Pacocha; Shanda R Birkeland; Stephen L Hajduk; Andrew G McArthur
Journal:  Eukaryot Cell       Date:  2006-08

2.  Steric constraints control processing of glycosylphosphatidylinositol anchors in Trypanosoma brucei.

Authors:  Carolina M Koeller; Calvin Tiengwe; Kevin J Schwartz; James D Bangs
Journal:  J Biol Chem       Date:  2020-01-13       Impact factor: 5.157

3.  Purification, cloning and characterization of a GPI inositol deacylase from Trypanosoma brucei.

Authors:  M L Güther; S Leal; N A Morrice; G A Cross; M A Ferguson
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

Review 4.  Secretory pathway of trypanosomatid parasites.

Authors:  Malcolm J McConville; Kylie A Mullin; Steven C Ilgoutz; Rohan D Teasdale
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

5.  Visualisation of experimentally determined and predicted protein N-glycosylation and predicted glycosylphosphatidylinositol anchor addition in Trypanosoma brucei.

Authors:  Michele Tinti; Michael A J Ferguson
Journal:  Wellcome Open Res       Date:  2022-01-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.